68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02038738|
Recruitment Status : Unknown
Verified January 2014 by Richard J. Campeau, M.D., FACNM, Ochsner Health System.
Recruitment status was: Not yet recruiting
First Posted : January 17, 2014
Last Update Posted : January 17, 2014
|Condition or disease||Intervention/treatment||Phase|
|Neuroendocrine Neuroendocrine Tumor Neuroendocrine Cancer Neuroendocrine Carcinoma Carcinoid Carcinoid Tumor Islet Cell Tumor Apudoma||Drug: 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography.||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||250 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors|
|Study Start Date :||March 2014|
|Estimated Primary Completion Date :||March 2019|
We will perform 68Ga-DOTATATE PET scans on subjects.
Drug: 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography.
- Number of Participants with Adverse Events as a Measure of Safety and Tolerability [ Time Frame: 5 years ]
- Number of lesions detected by 68Ga-DOTATATE compared to conventional imaging techniques [ Time Frame: 5 years ]
- We want to determine if the 68Ga-DOTATATE PET Scan changes care plans compared to conventional imaging/diagnostic techniques (Octreoscan, MRI, CT) [ Time Frame: 5 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02038738
|Contact: Richard J. Campeau, M.D.||504-464-8500|
|United States, Louisiana|
|Ochsner Medical Center - Kenner|
|Kenner, Louisiana, United States, 70065|